Specificity of autoantibodies react with ω-conotoxin MVIIC-sensitive calcium channel in Lambert-Eaton myasthenic syndrome

Muscle and Nerve

Volumn 19, Issue 9, 1996, Pages 1166-1168

  Suenaga, Akihito ^a   Shirabe, Susumu ^a   Nakamura, Tatsufumi ^a   Motomura, Masakatsu ^a   Tsujihata, Mitsuhiro ^b   Matsuo, Hidenori ^a   Kataoka, Yasufumi ^a   Niwa, Masami ^a   Itoh, Masao ^c   Nagataki, Shigenobu ^a  

^a NAGASAKI UNIVERSITY   (Japan)

^b Nagasaki Kita Hospital   (Japan)

^c EIKEN CHEMICAL CO LTD   (Japan)

Author keywords

conotoxin MVIIC; amyotrophic lateral sclerosis; Lambert Eaton myasthenic syndrome; myasthenia gravis; voltage gated calcium channel

Indexed keywords

AUTOANTIBODY; CALCIUM CHANNEL; CONOTOXIN;

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; EATON LAMBERT SYNDROME; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MYASTHENIA GRAVIS; PRIORITY JOURNAL;

ANTIBODY SPECIFICITY; AUTOANTIBODIES; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS; ELECTROPHYSIOLOGY; HUMANS; ION CHANNEL GATING; LAMBERT-EATON MYASTHENIC SYNDROME; OMEGA-CONOTOXINS; PEPTIDES;

EID: 9444278964     PISSN: 0148639X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4598(199609)19:9<1166::AID-MUS13>3.0.CO;2-T     Document Type: Article

References (10)

1. Bowersox S, Ko CP, Sugiura Y, Li CZ, Fox J, Hoffmann BB, Miljanich G: Omega-conopeptide SNX-230 (MVIIC) blocks calcium channels in mouse neuromuscular junction nerve terminals. Soc Neurosci Abstr 1993;19:1478.
2. Lambert EH, Elmqvist D: Quantal components of end-plate potentials in the myasthenic syndrome. Ann N Y Acad Sci 1971;183:183-199.
3. Lennon VA, Kryzer TJ, Griesmann GE, O'Suilleabhain PE, Windebank AJ, Woppmann A, Miljanich GP, Lambert EH: Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes. N Engl J Med 1995;332:1467-1474.
4. Lennon VA, Lambert EH: Autoantibodies bind solubilized calcium channel-oxonotoxin complexes from small cell lung carcinoma: a diagnostic aid for Lambert-Eaton myasthenic syndrome. Mayo Clin Proc 1989;64:1498-1504.
5. Leys K, Lang B, Johnston I, Newsom-Davis J: Calcium channel autoantibodies in the Lambert-Eaton myasthenic syndrome. Ann Neurol 1991;29:307-314.
6. Motomura M, Johnston I, Lang B, Vincent A, Newsom-Davis J: An improved diagnostic assay for Lambert-Eaton myasthenic syndrome. J Neurol Neurosurg Psychiatry 1995;58:85-87.
7. Sher E, Gotti C, Canal C, Scoppetta C, Piccolo G, Evoli A, Clementi F: Specificity of calcium channel autoantibodies in Lambert-Eaton myasthenic syndrome. Lancet 1989;2:640-643.
8. Swartz KJ, Mintz IM, Boland LM, Bean BP: Block of calcium channels in central and peripheral rat neurons by ω-conotoxin-MVIIC. Soc Neurosci Abstr 1993;19:1478.
9. 125I polypeptide hormones for radioimmunoassay using glucose oxidase with lactoperoxidase. Life Sci 1977;21:959-966.
10. Viglione MP, O'Shaughnessy TJ, Kim YI: Inhibition of calcium currents and exocytosis by Lambert-Eaton syndrome antibodies in human lung cancer cells. J Physiol (Lond) 1995; 488:303-317.